A&O Shearman
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Drawing upon a ‘deep knowledge of the private equity sector’, as well as having strong finance and corporate transactional expertise, A&O Shearman maintains a market-leading offering for financial sponsors on their downstream investment activity as well as on any exit processes. The team also benefits from access to a well-established network, ensuring they can provide ’high-quality feedback across jurisdictions’ on large cross-border transactions. A trusted adviser to many private capital clients, Jacques Graas is a key resource on sponsor-backed M&A, where he deploys a combination of ‘technical excellence, commercial pragmatism, and accessibility’. Fabian Beullekens handles a significant volume of private equity work in his role as head of M&A, often acting as lead adviser on multi-jurisdictional deals. Peter Myners has excellent insight into the sector, both through his fee-earning work as well as in his role as a Luxembourg Private Equity Association (LPEA) board member. Sylvain Cailleau and the recently promoted Pol Theisen round out the team on partner level.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'They are highly hands-on, pragmatic in their approach, and consistently deliver actionable advice.'
- 'They provide swift, high-quality feedback across jurisdictions.'
Work highlights
Advised The Riverside Company on its acquisition in 2019 of HealthTech BioActivies (HTBA), and then subsequently on its sale in 2024 to Miura Partners, a private equity firm that invests in Southern Europe.


